Clinical research professionals coordinating an active clinical trial in a research center

Advance your clinical programwith greater clarity.

Discuss Your Clinical Program For Investors

We support pharmaceutical and biotech teams by delivering specialized clinical research operations from trial authorization through marketing approval preparation.

Our AI-powered Clinical Research Intelligence platform centralizes program information and provides continuous visibility at every stage, helping teams advance complex clinical programs faster and with greater confidence.

Human expertise, strengthened by Clinical Research Intelligence.

Clinical Development Pathway

Clinical planning

After the required preclinical studies are complete, we translate the evidence into a clinical development strategy and design the first study in humans.

How we support you

We review the available evidence, identify remaining gaps and define the study objectives, population, dose approach, endpoints, protocol outline, timeline and required expertise.

Expert clinical guidance

Know whether the evidence, strategy, budget and operating plan are ready to support the first clinical submission.

Key deliverables

Clinical Development Plan
Target Product Profile
Clinical and regulatory gap assessment
Regulatory strategy and agency meeting package

First-in-human study synopsis
Population, endpoint and dose-escalation strategy
Pharmacokinetic, pharmacodynamic and biomarker strategy
Integrated timeline, budget and decision gates

Trial authorization

We prepare and coordinate the regulatory, ethics and operational requirements needed to authorize the trial and open participating sites.

How we support you

We coordinate the application package, ethics submissions, authority questions, country requirements, site feasibility and selection, essential documents, vendors and site activation.

Expert clinical guidance

See exactly what is blocking authorization or site opening and what must happen next to reach first-patient-in.

Key deliverables

Clinical trial application package
Final protocol and Investigator's Brochure
Informed consent and participant documents
Regulatory and ethics submission packages
Responses to authority and ethics questions

Site feasibility and selection reports
Site contracts, budgets and activation packages
Operational, data, safety and risk plans
Clinical database and electronic case report form
Site training and first-patient readiness package

Phase I

We lead first-in-human execution to establish safety, tolerability, pharmacokinetics and the dose range needed to progress development.

How we support you

We coordinate the study team, clinical sites or units, monitoring, safety oversight, data management, statistics, cohort reviews and study reporting.

Expert clinical guidance

Understand emerging safety, exposure and dose-escalation evidence before each cohort and progression decision.

Key deliverables

Cohort and dose-escalation plan
Safety review committee charter
Cohort safety and dose-decision packages
Pharmacokinetic and pharmacodynamic analyses
Monitoring, safety and data-quality reports

Clean and locked clinical database
Statistical tables, listings and figures
Clinical Study Report
Recommended dose and Phase II decision package

Phase II

We evaluate early efficacy in patients, refine the safety profile and generate the evidence needed to select the dose and design confirmatory studies.

How we support you

We coordinate sites, patient recruitment, monitoring, safety, data management, statistics, interim reviews and the clinical study report.

Expert clinical guidance

Determine whether efficacy, safety and dose-response evidence supports dose selection and investment in confirmatory development.

Key deliverables

Proof-of-concept or dose-ranging protocol
Recruitment and site strategy
Interim analysis plan
Data monitoring committee packages
Interim efficacy and safety analyses

Locked database and statistical outputs
Clinical Study Report
Dose-selection and Phase III recommendation
End-of-Phase II regulatory meeting package

Phase III

We coordinate large, often multicountry studies that confirm efficacy and safety and produce the pivotal evidence required for marketing authorization.

How we support you

We manage multicountry operations across sites, vendors, monitoring, safety, data management, statistics, reporting and study close-out.

Expert clinical guidance

Know whether execution, data quality and benefit-risk evidence remain on track for database lock and submission.

Key deliverables

Confirmatory protocol and global execution plan
Country, site and vendor-management plans
Risk-based monitoring and quality plans
Recruitment and retention reports
Monitoring, deviation and safety reports
Interim or data-monitoring committee packages

Safety and data reconciliation
Locked clinical database
Submission-standard datasets and outputs
Final Clinical Study Reports
Trial-results disclosure and plain-language summary
Inspection-readiness and Trial Master File package

Marketing application

We consolidate clinical data, analyses and study reports into the clinical dossier and support the sponsor throughout regulatory review.

How we support you

We coordinate clinical study reports, integrated efficacy and safety analyses, clinical dossier content, document review and responses to authority questions.

Expert clinical guidance

Confirm that every clinical claim is supported, traceable, reviewed and ready for authority assessment.

Key deliverables

Final Clinical Study Reports
Integrated Summary of Efficacy
Integrated Summary of Safety
Clinical Overview
Clinical Summary
Clinical Common Technical Document sections

Individual study reports and submission datasets
Clinical benefit-risk assessment
Clinical labeling support
Marketing application clinical package
Authority-question response packages
Inspection-readiness and data-publication package

Clinical Research Intelligence

From complex study signals to clearer decisions.

Critical insight is often lost when evidence, progress and decisions are considered separately. Clinical Research Intelligence restores the complete context of the program, helping research teams recognize what matters sooner, improve the quality, precision and consistency of their work, and move each phase forward through sharper analysis and more relevant reporting.

Project memory

Turn the program's complete memory into active knowledge that strengthens every analysis, handover and decision.

Cross analysis

Reveal what isolated views cannot see by connecting scientific meaning, operational reality and the evolving direction of the study.

Risk anticipation

Bring emerging threats into focus early enough to protect quality, preserve timelines and prepare the right response.

Expert reporting

Produce clearer reports with greater speed and consistency, while qualified professionals remain in control of every conclusion.

Innovative therapeutics

Clinical research expertiseFor innovative therapeutics.

Discuss Your Clinical Program

Experience across leading pharmaceutical and biotechnology organizations gives our engineers a practical understanding of the emerging therapeutic technologies, scientific complexity and clinical standards shaping the field.

Red Clinical combines that frontline expertise with Clinical Research Intelligence to interpret novel programs faster, structure stronger development pathways and move complex clinical work forward with greater precision.

Our clinical research engineers have experience with

Investor opportunity

Invest in a new model for clinical research.

Clinical expertise creates value today. Our intelligence layer is designed to improve the quality, speed and scalability of every program we support.

Red Clinical is creating a new model for innovative therapeutics: specialized clinical research operations strengthened by proprietary intelligence systems.

Biotechnology is entering a major growth cycle.
This round offers a rare opportunity to gain early exposure to the clinical research infrastructure required to support that expansion.

Pre-seed round

USD 2 million

Closing

December 2026

Expanding the clinical team, completing the first production platform and launching international client programs.

Request the investor brief